CLINICAL_TRIALS
trial_result
· 2009-01-14
Clinical Trial Update: Safety of Fentanyl TAIFUN Treatment [Phase 3]
Summary
Phase 3 trial update assessing the safety of fentanyl TAIFUN for breakthrough cancer pain.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Akela Pharma, Inc. | Conditions: Breakthrough Cancer Pain | Phase 3 | Status: UNKNOWN